MELK and cancer: Our data have also indicated that that the selective MELK inhibitor OTSSP167 could suppress the phosphorylation of these two MELK substrates, and has the in vitro and in vivo growth suppressive effect on cancer cells, implicating a great potential of this MELK inhibitor to apply to treatment of various types of human cancer.